Latest News

Dosage Adjustment to Increase Plasma Trough Levels Requires Investigation for Treatment of RCC and Sarcoma

Dosage Adjustment to Increase Plasma Trough Levels Requires Investigation for Treatment of RCC and Sarcoma

Individualized dosing should be studied to gauge whether subjectively increasing plasma has an impact on treatment.

VSIG10L Gene May Signify Susceptibility to Esophageal Adenocarcinoma

VSIG10L Gene May Signify Susceptibility to Esophageal Adenocarcinoma

VSIG10L may be a susceptibility gene for familial syndrome of esophageal adenocarcinoma and Barrett esophagus.

Half of Patients in Remission 11 Months After Nilotinib Discontinuation

Half of Patients in Remission 11 Months After Nilotinib Discontinuation

More than half of all patients with chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib remained in treatment-free remission.

TKI Duration and Molecular Response Pivotal for Survival With Chronic Myeloid Leukemia

TKI Duration and Molecular Response Pivotal for Survival With Chronic Myeloid Leukemia

For patients with chronic myeloid leukemia (CML), relapse-free remission with deep molecular response is possible.

Daratumumab Granted Breakthrough Therapy Designation for Use in Combination Regimens

Daratumumab Granted Breakthrough Therapy Designation for Use in Combination Regimens

The FDA granted Breakthrough Therapy Designation to daratumumab in combination for the treatment of patients with multiple myeloma.

Abnormal Uterine Bleeding May Signal Hematologic Cancer

Abnormal Uterine Bleeding May Signal Hematologic Cancer

Among women presenting with abnormal uterine bleeding (AUB), there is an estimated incidence of hematologic cancer of 3.6 cases per 1,000 women,.

Laproscopic and Open Prostatectomy Yield Similar 12-week Functional Outcomes

Laproscopic and Open Prostatectomy Yield Similar 12-week Functional Outcomes

Robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy are associated with similar functional outcomes at 12 weeks.

Ipilimumab Combination Appears Ineffective for Treatment of SCLC

Ipilimumab Combination Appears Ineffective for Treatment of SCLC

The addition of ipilimumab to etoposide and a platinum agent failed to prolong overall survival, when contrasted with chemotherapy only.

USPSTF States That Evidence is Insufficient to Recommend Visual Skin Cancer Screenings

USPSTF States That Evidence is Insufficient to Recommend Visual Skin Cancer Screenings

It is unclear whether clinician skin cancer screenings are more beneficial or harmful to people in the United States.

Less Cognitive Deterioration With Radiosurgery Among Patients With Brain Metastases

Less Cognitive Deterioration With Radiosurgery Among Patients With Brain Metastases

Among patients with 1 to 3 brain metastases, use of stereotactic radiosurgery (SRS) may result in less cognitive deterioration at 3 months.

Selinexor May Be Active in Advanced Sarcoma

Selinexor May Be Active in Advanced Sarcoma

Selinexor demonstrated preliminary activity and manageable toxicity in patients with advanced soft tissue or bone sarcoma.

Brentuximab Vedotin + AVD and ISRT Efficacious for Early Stage Hodgkin Lymphoma

Brentuximab Vedotin + AVD and ISRT Efficacious for Early Stage Hodgkin Lymphoma

Brentuximab vedotin with doxorubicin, vinblastine, and dacarbazine (AVD) followed by involved-site radiotherapy (ISRT) was efficacious.

Carfilzomib Efficacious Against Multiple Myeloma Regardless of Cytogenetic Abnormalities

Carfilzomib Efficacious Against Multiple Myeloma Regardless of Cytogenetic Abnormalities

The combination of carfilzomib, lenalidomide, and dexamethasone (KRd) may be more effective for the treatment of multiple myeloma.

Regions With More Radiotherapy Use Linked With More Mastectomies

Regions With More Radiotherapy Use Linked With More Mastectomies

Health service areas associated with more use of radiotherapy were correlated with an increased use of mastectomy at the time of a second breast event.

For Cancer Survivors, Guidelines Developed for Pain Management

For Cancer Survivors, Guidelines Developed for Pain Management

Guidelines have been developed for chronic pain management in adult cancer survivors.

Delirium Often Seen in Cancer Patients in Emergency Departments

Delirium Often Seen in Cancer Patients in Emergency Departments

Delirium is fairly common, yet often missed, in advanced cancer patients who visit emergency departments.

Vemurafenib Active in Progressive, RAI-refractory Papillary Thyroid Cancer

Vemurafenib Active in Progressive, RAI-refractory Papillary Thyroid Cancer

Vemurafenib showed activity in patients with progressive BRAFV600E mutation-positive papillary thyroid cancer refractory to radioactive iodine.

Chlorhexidine Dressing Reduces May Reduce Incidence of Catheter-related Bloodstream Infections

Chlorhexidine Dressing Reduces May Reduce Incidence of Catheter-related Bloodstream Infections

The application of chlorhexidine dressings may reduce the incidence of definite or probable catheter-related bloodstream infections (CRBSI).

Precision Treatment Improving for Head and Neck Cancers

Precision Treatment Improving for Head and Neck Cancers

To better treat recurrent and metastatic head and neck cancers, oncologists must better understand the molecular landscape by sequencing these tumors.

ABP 980 Biosimilar Not Inferior to Trastuzumab for Treatment of Breast Cancer

ABP 980 Biosimilar Not Inferior to Trastuzumab for Treatment of Breast Cancer

The biosimilar ABP 980 may not be inferior to trastuzumab for treatment of patients with HER2+ early breast cancer.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters